Jun 04, 2020
Taiho Oncology To Present Data on Futibatinib (TAS-120) at the AACR Annual Meeting 2020
Apr 27, 2020
Global Osteosarcoma Pipeline Insights, H1 2020: Therapeutics, Developments, Products, Drugs, Players
Mar 26, 2020
Medimetriks Announces that Otsuka Achieved Positive Top-Line Phase 3 Results for MM36 (difamilast) in Japanese Adult and Pediatric Atopic Dermatitis Patients
Nov 28, 2019
Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout
Nov 13, 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Nov 12, 2019
Avanir Pharmaceuticals, Inc. to Continue Clinical Development of Investigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia
Nov 01, 2019
Taiho Oncology Joins Efforts to Improve Awareness of Gastric Cancer with Support of Leading Advocacy Groups
Sep 26, 2019
Avanir Pharmaceuticals Announces Resolution of Government Investigation
Aug 29, 2019
Taiho Pharmaceutical Invests in New Venture Capital Fund
Jun 07, 2019
Taiho Oncology Announces Agreement with Otsuka to Commercialize Astex Pharmaceuticals' Drug Candidates
Jun 03, 2019
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Data at the 2019 ASCO Annual Meeting
Mar 01, 2019
Taiho Oncology Announces Support of Colorectal Cancer Awareness Month Through Research and Awareness Initiatives
Feb 25, 2019
FDA Approves Taiho Oncology's LONSURF® (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Feb 13, 2019
Avanir Pharmaceuticals, Inc. Reaches Agreement in Principle with U.S. Department of Justice Regarding NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) 20mg/10mg capsules
Feb 05, 2019
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor
Dec 11, 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA® Xsail®
Dec 03, 2018
Rockwell Medical, Inc. Appoints New Vice President, Marketing
Nov 28, 2018
Otsuka And Patrick J. Kennedy Lead Policy Forum Celebrating 10th Anniversary Of Mental Health Parity And Addiction Equity Act
Nov 16, 2018
Otsuka Pharmaceutical Development & Commercialization, Inc. Hosts Roundtable on Healthcare and Technology with U.S. Representative Bonnie Watson Coleman
Oct 21, 2018
Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology